ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Gallo Actively Searching For New Position

July 1, 1994

Former Group Chair Responds To Niederhuber: Change But Don’t Dissolve Cooperative Groups

July 2, 2010

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

May 31, 1996

Wong To Head MSKCC Colorectal Service; How You Know When To Stop Advising NCI.

June 29, 2001

In Turnaround, NCAB To Advise Screening Mammography for Women In Their Forties

March 28, 1997

BRMP Projects Priority Rated

April 11, 1980